Mutations inSYNGAP1in Autosomal Nonsyndromic Mental Retardation
Author(s) -
Fadi F. Hamdan,
Julie Gauthier,
Dan Spiegelman,
Anne Noreau,
Yanlian Yang,
Stéphanie Pellerin,
Sylvia Dobrzeniecka,
Mélanie Côté,
Elizabeth Perreau-Linck,
Lionel Carmant,
Guy D’Anjou,
Éric Fombonne,
Anjené Addington,
Judith L. Rapoport,
Lynn E. DeLisi,
MarieOdile Krebs,
Fayçal Mouaffak,
Ridha Joober,
Laurent Mottron,
Pierre Drapeau,
Claude Marineau,
Ronald G. Lafrenière,
Jean Claude Lacaille,
Guy A. Rouleau,
Jacques L. Michaud
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0805392
Subject(s) - autism , genetics , medicine , schizophrenia (object oriented programming) , autism spectrum disorder , developmental disorder , psychiatry , biology
Although autosomal forms of nonsyndromic mental retardation account for the majority of cases of mental retardation, the genes that are involved remain largely unknown. We sequenced the autosomal gene SYNGAP1, which encodes a ras GTPase-activating protein that is critical for cognition and synapse function, in 94 patients with nonsyndromic mental retardation. We identified de novo truncating mutations (K138X, R579X, and L813RfsX22) in three of these patients. In contrast, we observed no de novo or truncating mutations in SYNGAP1 in samples from 142 subjects with autism spectrum disorders, 143 subjects with schizophrenia, and 190 control subjects. These results indicate that SYNGAP1 disruption is a cause of autosomal dominant nonsyndromic mental retardation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom